Continue to site >
Trending ETFs

ProShares Ultra Nasdaq Biotechnology

ETF
BIB
Dividend policy
Suspended
Price as of:
$89.34 -1.21 -1.34%
primary theme
Leveraged Equity
BIB (ETF)

ProShares Ultra Nasdaq Biotechnology

Dividend policy
Suspended
Price as of:
$89.34 -1.21 -1.34%
primary theme
Leveraged Equity
BIB (ETF)

ProShares Ultra Nasdaq Biotechnology

Dividend policy
Suspended
Price as of:
$89.34 -1.21 -1.34%
primary theme
Leveraged Equity

Name

Price

Aum/Mkt Cap

YIELD & DIV

Exp Ratio

Watchlist

$89.34

$284 M

0.00%

$0.00

0.95%

Vitals

YTD Return

3.5%

1 yr return

35.3%

3 Yr Avg Return

10.8%

5 Yr Avg Return

14.3%

Net Assets

$284 M

Holdings in Top 10

N/A

52 WEEK LOW AND HIGH

$88.2
$64.59
$111.49

Expenses

OPERATING FEES

Expense Ratio 0.95%

SALES FEES

Front Load N/A

Deferred Load N/A

TRADING FEES

Turnover 37.00%

Redemption Fee N/A


Min Investment

Standard (Taxable)

N/A

IRA

N/A


Fund Classification

Fund Type

Exchange Traded Fund

Investment Style

Trading--Leveraged Equity


Name

Price

Aum/Mkt Cap

YIELD & DIV

Exp Ratio

Watchlist

$89.34

$284 M

0.00%

$0.00

0.95%

BIB - Profile

Distributions

  • YTD Total Return 4.9%
  • 3 Yr Annualized Total Return 10.8%
  • 5 Yr Annualized Total Return 14.3%
  • Capital Gain Distribution Frequency N/A
  • Net Income Ratio -0.58%
DIVIDENDS
  • Dividend Yield 0.0%
  • Dividend Distribution Frequency Quarterly

Fund Details

  • Legal Name
    ProShares Ultra Nasdaq Biotechnology
  • Fund Family Name
    ProShares
  • Inception Date
    Apr 06, 2010
  • Shares Outstanding
    3000000
  • Share Class
    N/A
  • Currency
    USD
  • Domiciled Country
    United States
  • Manager
    Michael Neches

Fund Description

The fund invests in financial instruments that ProShare Advisors believes, in combination, should produce daily returns consistent with the fund's investment objective. The index is a modified capitalization weighted index that includes securities of Nasdaq listed companies that are classified as either biotechnology or pharmaceutical. The fund is non-diversified.


BIB - Performance

Return Ranking - Trailing

Period BIB Return Category Return Low Category Return High Rank in Category (%)
YTD 3.5% -91.0% 217.1% 71.43%
1 Yr 35.3% -60.3% 406.4% 70.27%
3 Yr 10.8%* -81.9% 74.8% 45.98%
5 Yr 14.3%* -64.9% 66.1% 59.15%
10 Yr 29.6%* -51.1% 59.4% 19.42%

* Annualized

Return Ranking - Calendar

Period BIB Return Category Return Low Category Return High Rank in Category (%)
2020 39.8% -77.6% 1505.0% 26.01%
2019 46.7% -58.1% 806.3% 43.11%
2018 -24.9% -78.0% 36.9% 50.89%
2017 40.5% -70.1% 314.9% 41.10%
2016 -44.2% -82.0% 1431.2% 96.25%

Total Return Ranking - Trailing

Period BIB Return Category Return Low Category Return High Rank in Category (%)
YTD 4.9% -91.2% 218.8% 70.86%
1 Yr 35.3% -60.3% 406.4% 69.73%
3 Yr 10.8%* -81.9% 74.8% 45.40%
5 Yr 14.3%* -64.9% 66.1% 58.54%
10 Yr 29.6%* -51.1% 59.4% 19.42%

* Annualized

Total Return Ranking - Calendar

Period BIB Return Category Return Low Category Return High Rank in Category (%)
2020 39.8% -97.4% 379.3% 23.12%
2019 46.7% -58.1% 229.8% 42.51%
2018 -24.9% -74.3% 36.9% 52.66%
2017 40.5% -40.2% 263.7% 45.40%
2016 -44.2% -62.9% 167.0% 99.38%

BIB - Holdings

Concentration Analysis

BIB Category Low Category High BIB % Rank
Net Assets 284 M 445 K 14.7 B 19.42%
Number of Holdings 282 1 2053 14.53%
Net Assets in Top 10 396 M 643 34 B 16.76%
Weighting of Top 10 N/A 23.2% 100.0% N/A

Top 10 Holdings

  1. Nasdaq Biotechnology Index Swap Societe Generale 38.51%
  2. Nasdaq Biotechnology Index Swap Societe Generale 38.51%
  3. Nasdaq Biotechnology Index Swap Societe Generale 38.51%
  4. Nasdaq Biotechnology Index Swap Societe Generale 38.51%
  5. Nasdaq Biotechnology Index Swap Societe Generale 38.51%
  6. Nasdaq Biotechnology Index Swap Societe Generale 38.51%
  7. Nasdaq Biotechnology Index Swap Societe Generale 38.51%
  8. Nasdaq Biotechnology Index Swap Societe Generale 38.51%
  9. Nasdaq Biotechnology Index Swap Societe Generale 38.51%
  10. Nasdaq Biotechnology Index Swap Societe Generale 38.51%

Asset Allocation

Weighting Return Low Return High BIB % Rank
Stocks
200.13% -3.25% 300.03% 10.61%
Preferred Stocks
0.00% 0.00% 0.02% 50.28%
Other
0.00% -5.60% 195.40% 62.01%
Convertible Bonds
0.00% 0.00% 0.07% 54.75%
Bonds
0.00% 0.00% 45.01% 67.04%
Cash
-100.13% -200.03% 103.25% 88.27%

Stock Sector Breakdown

Weighting Return Low Return High BIB % Rank
Utilities
0.00% 0.00% 100.00% 60.14%
Technology
0.00% 0.00% 100.00% 76.92%
Real Estate
0.00% 0.00% 100.00% 55.24%
Industrials
0.00% 0.00% 100.00% 77.62%
Healthcare
0.00% 0.00% 100.00% 4.20%
Financial Services
0.00% 0.00% 100.00% 73.43%
Energy
0.00% 0.00% 100.00% 63.64%
Communication Services
0.00% 0.00% 100.00% 76.92%
Consumer Defense
0.00% 0.00% 64.70% 69.93%
Consumer Cyclical
0.00% 0.00% 94.44% 75.52%
Basic Materials
0.00% 0.00% 100.00% 52.45%

Stock Geographic Breakdown

Weighting Return Low Return High BIB % Rank
US
179.87% -36.27% 300.01% 15.08%
Non US
20.26% 0.00% 200.33% 16.76%

BIB - Expenses

Operational Fees

BIB Fees (% of AUM) Category Return Low Category Return High Rank in Category (%)
Expense Ratio 0.95% 0.35% 2.78% 81.19%
Management Fee 0.75% 0.00% 0.95% 42.72%
12b-1 Fee N/A 0.00% 1.00% N/A
Administrative Fee N/A 0.03% 0.25% N/A

Sales Fees

BIB Fees (% of AUM) Category Return Low Category Return High Rank in Category (%)
Front Load N/A 4.75% 4.75% N/A
Deferred Load N/A 1.00% 1.00% N/A

Trading Fees

BIB Fees (% of AUM) Category Return Low Category Return High Rank in Category (%)
Max Redemption Fee N/A N/A N/A N/A

Related Fees

Turnover provides investors a proxy for the trading fees incurred by mutual fund managers who frequently adjust position allocations. Higher turnover means higher trading fees.

BIB Fees (% of AUM) Category Return Low Category Return High Rank in Category (%)
Turnover 37.00% 0.00% 376.00% 20.14%

BIB - Distributions

Dividend Yield Analysis

BIB Category Low Category High BIB % Rank
Dividend Yield 0.00% 0.00% 0.10% 47.57%

Dividend Distribution Analysis

BIB Category Low Category High Category Mod
Dividend Distribution Frequency Quarterly Annually Quarterly Annually

Net Income Ratio Analysis

BIB Category Low Category High BIB % Rank
Net Income Ratio -0.58% -2.77% 2.92% 55.15%

Capital Gain Distribution Analysis

BIB Category Low Category High Capital Mode
Capital Gain Distribution Frequency Annually Annually Annually

Dividend Payout History

View More +

BIB - Fund Manager Analysis

Managers

Michael Neches


Start Date

Tenure

Tenure Rank

Oct 01, 2013

8.0

8.0%

Michael Neches joined ProShare Advisors in 2000, and presently serves as a Senior Portfolio Manager. He previously served as the Senior Portfolio Manager responsible for the company’s commodities desk for two years, as a Portfolio Manager and team lead, as an Associate Portfolio Manager and as a Portfolio Analyst. Mr. Neches earned a Bachelor of Science in Finance from the University of Maryland, College Park and an MBA from Georgetown University.

Tarak Davé


Start Date

Tenure

Tenure Rank

Apr 30, 2018

3.42

3.4%

Tarak Dave ProFund Advisors LLC: Portfolio Manager since March 2018, Associate Portfolio Manager from November 2015 to March 2018, Senior Portfolio Analyst from May 2014 to October 2015 and Portfolio Analyst from April 2011 to April 2014.

Tenure Analysis

Category Low Category High Category Average Category Mode
0.02 28.24 7.11 8.0